Valproic AcId for Traumatic BRAin INjury Trial
Key facts
- Who runs it
- Northwestern University
- Where
- Birmingham, Chicago, Dallas, Los Angeles, Milwaukee, Nashville, Portland, Sacramento, and Tucson, United StatesSee the 9 sites
- Trial code
- Status
- Not yet recruiting
- Phase
- Phase 2/3
- People taking part
- 432 people, planned
- Starts
- May 2027
- Expected to end
- Dec 2031
- Type of study
- Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- Valproic Acid (VPA)
- Standard of care treatment + normal saline
- Record updated
- 5 November 2026
Who can take part
- Age
- 18 years to 65 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 22 criteriaShow less
Who can take part
- Male or female between the ages of 18 and 65 years
- Body Mass Index between 18 kg/m2 and 35 kg/m2
- Females must be surgically sterilized, postmenopausal, or have a negative urine pregnancy test
- Moderate to severe TBI: Glasgow Coma Scale (GCS) 3-12
- Cerebral trauma confirmed on the initial CT scan with radiographic findings consistent with Brain Injury Guidelines category 3 (BIG 3) criteria
Who cannot take part
- Persons with a known "do not resuscitate" order prior to randomization
- Persons with known history of adverse reactions to VPA
- Persons with known history of hepatitis B or C or clinical history of hepatic dysfunction, pancreatitis, or renal insufficiency
- Persons with a known history of thrombocytopenia
- Persons with platelet count less than 100,000 per microliter of blood
- Persons with 2nd or 3rd degree burns of any size and location
- Female subjects who are pregnant or lactating
- Persons who are currently incarcerated or are in police custody
- Persons with inadequate venous access
- Treatment cannot start within 120 minutes from the onset of injury
- Non-survivable injuries in the estimation of the attending trauma surgeon
- Interfacility transfers
- The time of injury is unknown
- Patients in hemorrhagic shock with a systolic blood pressure of <90 mmHg on initial evaluation
- Persons with a research "opt out" bracelet
- Persons who are currently enrolled in another clinical trial
- Greater than 90 minutes between the onset of injury and arrival to the hospital
The main criteria, as questions
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 65 years old?
Where in United States
- University of Alabama at BirminghamBirmingham, United StatesContact: Joel RodgersNot yet recruiting
- Northwestern UniversityChicago, United StatesContact: Sharnia Lashley, MSNot yet recruiting
- University of Texas, SouthwesternDallas, United StatesContact: Katherine BoslerNot yet recruiting
- University of Southern CaliforniaLos Angeles, United StatesContact: Monica WongNot yet recruiting
- Medical College of WisconsinMilwaukee, United StatesContact: Madison Rundell, BSNot yet recruiting
- Vanderbilt University Medical CenterNashville, United StatesContact: Heather WhiteNot yet recruiting
- Oregon Health Science UniversityPortland, United StatesContact: Samanatha UnderwoodNot yet recruiting
- University of California - DavisSacramento, United StatesContact: Shari NicholsNot yet recruiting
- University of ArizonaTucson, United StatesContact: Robin Carlson, PhDNot yet recruiting
About the trial
What the trial wants to find out
The long-term goal of the clinical trial is to develop effective, safe, and easily administered life-saving treatments for patients with moderate to severe traumatic brain injury (TBI).
Read full original descriptionShow less
Patients with moderate to severe TBI will randomly receive either:
1. Standard of care treatment and normal saline 2. Standard of care treatment and one dose of valproic acid (VPA) at a lower dose or a higher dose
The 2 groups in the trial
- ControlPlacebo, for comparison
Standard of Care + Normal Saline (0.9% sodium chloride solution)
Treatment: Standard of care treatment + normal saline
- ExperimentalTreatment being tested
Standard of care treatment + one dose of VPA (in 250 ml 0.9% sodium chloride solution) in the following two doses: * Lower dose VPA: 50 mg/kg * Higher dose VPA: 100 mg/kg
Treatment: Valproic Acid (VPA)
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Multi-institutional Phase 2/3 Trial of Valproic Acid in Patients With Moderate to Severe Traumatic Brain Injury
- Criteria questions
- Built from NCT07166393, who can take part
- Publications
- Record updated
- 5 November 2026